News Daily News AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD Caitlin E. Cox December 28, 2021
News Daily News Upping Generic CV Drug Scripts Could Save Medicare and Patients Millions L.A. McKeown December 17, 2021
News Daily News Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF L.A. McKeown December 07, 2021
News Conference News TCT 2021 GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF Michael O'Riordan November 06, 2021
News Conference News TCT 2021 Renal Denervation May Help Cut BP Meds, Sham-Controlled Trial Hints Todd Neale November 04, 2021
News Features Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle Shelley Wood October 08, 2021
News Conference News HFSA 2021 PRESERVED-HF: Dapagliflozin Improves Symptoms, Physical Limitations in HFpEF Todd Neale September 13, 2021
News Conference News ESC 2021 GUIDE-HF: Pulmonary Artery Sensor May Help in Mild HF, but COVID-19 Muddies Water Shelley Wood August 27, 2021
News Conference News TVT 2021 Optimizing Medical Therapy Before Clip Repair for MR? ‘This Is Hard’ Todd Neale July 27, 2021
News Conference News TVT 2021 Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market Todd Neale July 22, 2021
News Conference News EuroPCR 2021 Tricuspid Trio: TRISCEND, CLASP TR, and TriBAND Studies Show Advances Caitlin E. Cox May 21, 2021
News Conference News ACC 2021 Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO Michael O'Riordan May 16, 2021
News Daily News AHA Highlights Unique Needs of Opioid-Associated Cardiac Arrest Shelley Wood March 18, 2021
News Daily News FDA Approves Vericiguat for High-risk Patients With HF Michael O'Riordan January 20, 2021